Cytotoxic T lymphocyte antigen-4 (CTLA-4) als therapeutisches Target in der Tumorimmuntherapie
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Bibliographic citation
-
Cytotoxic T lymphocyte antigen-4 (CTLA-4) als therapeutisches Target in der Tumorimmuntherapie ; volume:62 ; number:S 01 ; year:2012 ; pages:S9-S10 ; 01
Arzneimittelforschung ; 62, Heft S 01 (2012), S9-S10, 01
- Contributor
- DOI
-
10.1055/s-0032-1324904
- URN
-
urn:nbn:de:101:1-2018121211074711179434
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
Other Objects (12)
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
The role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in atherosclerosis
Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A>G) and migraine
Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors
Assoziationsuntersuchung des Cytotoxic-T-Lymphocyte-Antigen-4 (CTLA4)-Gens im Fall-Kontroll-Design bei Alopecia areata
Cytotoxic T lymphocyte responses against melanocytes and melanoma
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies
Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
The role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in atherosclerosis
Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A>G) and migraine
Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors
Assoziationsuntersuchung des Cytotoxic-T-Lymphocyte-Antigen-4 (CTLA4)-Gens im Fall-Kontroll-Design bei Alopecia areata
Cytotoxic T lymphocyte responses against melanocytes and melanoma
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies
Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
The role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in atherosclerosis
Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A>G) and migraine
Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors
Assoziationsuntersuchung des Cytotoxic-T-Lymphocyte-Antigen-4 (CTLA4)-Gens im Fall-Kontroll-Design bei Alopecia areata
Cytotoxic T lymphocyte responses against melanocytes and melanoma
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies